Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)

Completed · Phase 3 · Has a placebo group

Conditions studied: Rhinitis, Allergic, Perennial

In brief

The purpose of the study is to assess the efficacy and safety of an investigational nasal aerosol compared with placebo nasal aerosol in the treatment of perennial allergic rhinitis.

Key facts

Study ID

NCT01134705

Run by

Teva Branded Pharmaceutical Products R&D, Inc.

People needed

474

Starts

2010-05-01

Expected to finish

2010-10-01

Last updated by the study team

2012-05-23

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Informed Consent
• Documented history of perennial allergic rhinitis
• A demonstrated sensitivity to at least one allergen known to induce PAR through a standard skin prick test.
• Minimum subject-reported reflective total nasal symptom score (rTNSS) of at least 6 (out of a possible 12)
• Other criteria apply

You may not qualify if…

• History of physical findings of nasal pathology (within 60 days prior to screening visit)
• Participation in any investigational drug study 30 days preceding screening visit
• History of respiratory infection/disorder with 14 days preceding screening visit or during the run-in period
• Use of any prohibited concomitant medications

Where it is running

• Teva Clinical Study Site — Los Angeles, California, United States
• Teva Clinical Study Site — Mission Viejo, California, United States
• Teva Clinical Study Site — San Diego, California, United States
• Teva Clinical Study Site — San Jose, California, United States
• Teva Clinical Study Site — Miami, Florida, United States
• Teva Clinical Study Site — Tallahassee, Florida, United States
• Teva Clinical Study Site — Lilburn, Georgia, United States
• Teva Clinical Study Site — Indianapolis, Indiana, United States
• Teva Clinical Study Site — Bangor, Maine, United States
• Teva Clinical Study Site — Bethesda, Maryland, United States
• Teva Clinical Study Site — Rolla, Missouri, United States
• Teva Clinical Study Site — St Louis, Missouri, United States
• Teva Clinical Study Site — Brick, New Jersey, United States
• Teva Clinical Study Site — Raleigh, North Carolina, United States
• Teva Clinical Study Site — Winston-Salem, North Carolina, United States
• Teva Clinical Study Site — Canton, Ohio, United States
• Teva Clinical Study Site — Medford, Oregon, United States
• Teva Clinical Study Site — Portland, Oregon, United States
• Teva Clinical Study Site — Blue Bell, Pennsylvania, United States
• Teva Clinical Study Site — Upland, Pennsylvania, United States
• Teva Clinical Study Site — Providence, Rhode Island, United States
• Teva Clinical Study Site — Charleston, South Carolina, United States
• Teva Clinical Study Site — Spartanburg, South Carolina, United States
• Teva Clinical Study Site — Austin, Texas, United States
• Teva Clinical Study Site — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.